Central voice production and pathophysiology of spasmodic dysphonia

被引:23
作者
Mor, Niv [1 ]
Simonyan, Kristina [2 ,3 ]
Blitzer, Andrew [2 ,4 ]
机构
[1] Maimonides Hosp, Voice & Swallowing Disorders, Div Otolaryngol Head & Neck Surg, 919 49th St, Brooklyn, NY 11219 USA
[2] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA
[3] Icahn Sch Med Mt Sinai, Dept Otolaryngol Head & Neck Surg, New York, NY 10029 USA
[4] New York Ctr Voice & Swallowing Disorders, New York, NY USA
关键词
Laryngeal motor cortex; phonation; voice; spasmodic dysphonia; laryngeal dystonia; botulinum toxin; ADDUCTOR DENERVATION-REINNERVATION; THYROARYTENOID MUSCLE RESPONSES; LARYNGEAL MYOTATIC REFLEXES; AIR-PRESSURE STIMULATION; NERVOUS-SYSTEM CONTROL; TERM-FOLLOW-UP; SPASTIC DYSPHONIA; BOTULINUM TOXIN; MOTOR CORTEX; DYSTONIA;
D O I
10.1002/lary.26655
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
ObjectiveOur ability to speak is complex, and the role of the central nervous system in controlling speech production is often overlooked in the field of otolaryngology. In this brief review, we present an integrated overview of speech production with a focus on the role of central nervous system. The role of central control of voice production is then further discussed in relation to the potential pathophysiology of spasmodic dysphonia (SD). Data SourcesPeer-review articles on central laryngeal control and SD were identified from PUBMED search. Selected articles were augmented with designated relevant publications. Review MethodsPublications that discussed central and peripheral nervous system control of voice production and the central pathophysiology of laryngeal dystonia were chosen. ResultsOur ability to speak is regulated by specialized complex mechanisms coordinated by high-level cortical signaling, brainstem reflexes, peripheral nerves, muscles, and mucosal actions. Recent studies suggest that SD results from a primary central disturbance associated with dysfunction at our highest levels of central voice control. The efficacy of botulinum toxin in treating SD may not be limited solely to its local effect on laryngeal muscles and also may modulate the disorder at the level of the central nervous system. ConclusionFuture therapeutic options that target the central nervous system may help modulate the underlying disorder in SD and allow clinicians to better understand the principal pathophysiology. Level of EvidenceNA.Laryngoscope, 128:177-183, 2018
引用
收藏
页码:177 / 183
页数:7
相关论文
共 50 条
  • [41] Use of Botulinum Toxin in Spasmodic Dysphonia: A Review of Recent Studies
    Khan, Hammaad A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [42] Spasmodic Dysphonia: A Review. Part 1: Pathogenic Factors
    Hintze, Justin M.
    Ludlow, Christy L.
    Bansberg, Stephen F.
    Adler, Charles H.
    Lott, David G.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2017, 157 (04) : 551 - 557
  • [43] Treatment of spasmodic dysphonia with homeopathic medicine: a clinical case report
    Xue, Steve An
    de Schepper, Luc
    Hao, Grace Jianping
    HOMEOPATHY, 2009, 98 (01) : 56 - 59
  • [44] Singer's dystonia: First report of a variant of spasmodic dysphonia
    Chitkara, A
    Meyer, T
    Keidar, A
    Blitzer, A
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2006, 115 (02) : 89 - 92
  • [45] Combined Modality Treatment of Adductor Spasmodic Dysphonia
    Silverman, Erin P.
    Garvan, Cynthia
    Shrivastav, Rahul
    Sapienza, Christine M.
    JOURNAL OF VOICE, 2012, 26 (01) : 77 - 86
  • [46] Effects and Differences of Voice Therapy on Spasmodic Dysphonia and Muscle tension dysphonia: A Retrospective Pilot Study
    Kodama, Narihiro
    Sanuki, Tetsuji
    Miyamoto, Takumi
    Tashiro, Joji
    JOURNAL OF VOICE, 2024, 38 (01) : 129 - 135
  • [47] Efficacy of botulinum toxin in treatment of spasmodic dysphonia
    Petrovic, Igor
    Svetel, Marina
    Vasic, Milan
    Kostic, Vladimir
    TOXICON, 2008, 51 : 34 - 34
  • [48] COMBINED-MODALITY TREATMENT OF ADDUCTOR SPASMODIC DYSPHONIA WITH BOTULINUM TOXIN AND VOICE THERAPY
    MURRY, T
    WOODSON, GE
    JOURNAL OF VOICE, 1995, 9 (04) : 460 - 465
  • [49] Factors influencing long-term treatment response to botulinum toxin injection for spasmodic dysphonia
    Kang, Min Seok
    Lee, Seung Jin
    Choi, Hong-Shik
    Lim, Jae-Yol
    CLINICAL OTOLARYNGOLOGY, 2021, 46 (02) : 436 - 444
  • [50] Consensus-Based Attributes for Identifying Patients With Spasmodic Dysphonia and Other Voice Disorders
    Ludlow, Christy L.
    Domangue, Rickie
    Sharma, Dinesh
    Jinnah, H. A.
    Perlmutter, Joel S.
    Berke, Gerald
    Sapienza, Christine
    Smith, Marshall E.
    Blumin, Joel H.
    Kalata, Carrie E.
    Blindauer, Karen
    Johns, Michael
    Hapner, Edie
    Harmon, Archie
    Paniello, Randal
    Adler, Charles H.
    Crujido, Lisa
    Lott, David G.
    Bansberg, Stephen F.
    Barone, Nicholas
    Drulia, Teresa
    Stebbins, Glenn
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2018, 144 (08) : 657 - 665